Ro 6-3129: Difference between revisions
Content deleted Content added
Entranced98 (talk | contribs) Importing Wikidata short description: "Chemical compound" |
consistent citation formatting |
||
Line 29: | Line 29: | ||
<!-- Identifiers --> |
<!-- Identifiers --> |
||
| CAS_number_Ref = |
| CAS_number_Ref = |
||
| CAS_number = |
| CAS_number = 39729-35-6 |
||
| CAS_supplemental = |
| CAS_supplemental = |
||
| ATC_prefix = |
| ATC_prefix = |
||
Line 55: | Line 55: | ||
}} |
}} |
||
'''Ro 6-3129''', also known as '''16α-ethylthio-6-dehydroretroprogesterone''' or as '''16α-ethylthio-9β,10α-pregna-4,6-diene-3,20-dione''', as well as '''16α-ethylthiodydrogesterone''', is a [[progestogen]] of the [[retroprogesterone]] group which was developed by [[Hoffmann-La Roche|Roche]] but was never marketed.<ref name="JUCKER2013">{{cite |
'''Ro 6-3129''', also known as '''16α-ethylthio-6-dehydroretroprogesterone''' or as '''16α-ethylthio-9β,10α-pregna-4,6-diene-3,20-dione''', as well as '''16α-ethylthiodydrogesterone''', is a [[progestogen]] of the [[retroprogesterone]] group which was developed by [[Hoffmann-La Roche|Roche]] but was never marketed.<ref name="JUCKER2013">{{cite journal | vauthors = Harper MJ | title = Contraception--retrospect and prospect | veditors = Jucker E | journal = Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques | volume = 21 | issue = | pages = 293–407 (321) | date = 1977 | pmid = 339271 | doi = 10.1007/978-3-0348-7098-6_4 | isbn=978-3-0348-7098-6 |url=https://books.google.com/books?id=VFb2BwAAQBAJ&pg=PA321 }}</ref><ref name="pmid5458777">{{cite journal | vauthors = Larsson-Cohn U, Johansson ED, Wide L, Gemzell C | title = Effects of daily administration of a retrosteroid on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens | journal = The Journal of Obstetrics and Gynaecology of the British Commonwealth | volume = 77 | issue = 9 | pages = 840–846 | date = September 1970 | pmid = 5458777 | doi = 10.1111/j.1471-0528.1970.tb04411.x | s2cid = 6176278 }}</ref><ref name="DixonHudson1973">{{cite journal| vauthors = Dixon R, Hudson S, Darragh A |title=Pharmacokinetics of the retro-steroid progestogen, 16α-ethylthio-9β,10α-pregna-4, 6-diene-3, 20-dione (Ro 6-3129), in man and the sheep|journal=Contraception|volume=8|issue=1|year=1973|pages=53–65|issn=0010-7824|doi=10.1016/0010-7824(73)90159-5}}</ref> It shows greater [[potency (pharmacology)|potency]] than [[dydrogesterone]] in [[bioassay]]s.<ref name="RoyalCollege1970">{{cite book|title=The Journal of Obstetrics and Gynaecology of the British Commonwealth|url=https://books.google.com/books?id=_gtA33qrWkIC|year=1970|publisher=Royal College of Obstetricians and Gynaecologists}}</ref> |
||
==References== |
== References == |
||
{{Reflist}} |
{{Reflist}} |
||
{{Progesterone receptor modulators}} |
{{Progesterone receptor modulators}} |
||
Line 70: | Line 69: | ||
[[Category:Progestogens]] |
[[Category:Progestogens]] |
||
[[Category:Thioethers]] |
[[Category:Thioethers]] |
||
{{Steroid-stub}} |
{{Steroid-stub}} |
Revision as of 18:13, 9 August 2023
Clinical data | |
---|---|
Other names | 16α-Ethylthiodydrogesterone; 16α-Ethylthio-6-dehydroretroprogesterone; 16α-Ethylthio-9β,10α-pregna-4,6-diene-3,20-dione |
Routes of administration | Oral |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
Chemical and physical data | |
Formula | C23H32O2S |
Molar mass | 372.57 g·mol−1 |
3D model (JSmol) | |
| |
|
Ro 6-3129, also known as 16α-ethylthio-6-dehydroretroprogesterone or as 16α-ethylthio-9β,10α-pregna-4,6-diene-3,20-dione, as well as 16α-ethylthiodydrogesterone, is a progestogen of the retroprogesterone group which was developed by Roche but was never marketed.[1][2][3] It shows greater potency than dydrogesterone in bioassays.[4]
References
- ^ Harper MJ (1977). Jucker E (ed.). "Contraception--retrospect and prospect". Progress in Drug Research. Fortschritte der Arzneimittelforschung. Progres des Recherches Pharmaceutiques. 21: 293–407 (321). doi:10.1007/978-3-0348-7098-6_4. ISBN 978-3-0348-7098-6. PMID 339271.
- ^ Larsson-Cohn U, Johansson ED, Wide L, Gemzell C (September 1970). "Effects of daily administration of a retrosteroid on the plasma levels of progesterone and on the urinary excretion of luteinizing hormone and total oestrogens". The Journal of Obstetrics and Gynaecology of the British Commonwealth. 77 (9): 840–846. doi:10.1111/j.1471-0528.1970.tb04411.x. PMID 5458777. S2CID 6176278.
- ^ Dixon R, Hudson S, Darragh A (1973). "Pharmacokinetics of the retro-steroid progestogen, 16α-ethylthio-9β,10α-pregna-4, 6-diene-3, 20-dione (Ro 6-3129), in man and the sheep". Contraception. 8 (1): 53–65. doi:10.1016/0010-7824(73)90159-5. ISSN 0010-7824.
- ^ The Journal of Obstetrics and Gynaecology of the British Commonwealth. Royal College of Obstetricians and Gynaecologists. 1970.